According to a market report by Lucintel, the future of the global fibromuscular dysplasia treatment market looks promising with opportunities in the hospitals pharmacies, retail pharmacies, and online pharmacies markets. The global fibromuscular dysplasia treatment market is expected to grow with a CAGR of 7.3% from 2024 to 2030. The major drivers for this market are increasing incidence of hypertension across the global population and rising occurrence of smoking.
A more than 150–page report is developed to understand Trends,
opportunity and forecast in fibromuscular dysplasia treatment market to 2030 by
drug class (angiotensin-converting enzyme inhibitors, angiotensin II receptor
blockers, diuretics, calcium channel blockers, beta-blockers, and others),
distribution channel (hospitals pharmacies, retail pharmacies, and online
pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of
the World).
In this market, angiotensin-converting enzyme inhibitors, and angiotensin
II receptor blockers, diuretics, calcium channel blockers, and beta-blockers
are the major segments of fibromuscular dysplasia treatment market by drug
class. Lucintel forecasts that angiotensin II receptor blockers is expected to
witness the highest growth over the forecast period.
Within this market, hospitals pharmacies will remain the largest segment.
Download sample by clicking on fibromuscular
dysplasia treatment market.
North America is expected to witness highest growth over the forecast
period.
ALVOGEN, Aspen Surgical Products, AstraZeneca, B. Braun Melsungen, Bayer
Healthcare Pharmaceuticals, Becton, Dickinson & Company, Pfizer,
Sanofi-Aventis, and Smith & Nephew are the major suppliers in the
fibromuscular dysplasia treatment market.
This unique research report will enable you to make confident business
decisions in this globally competitive marketplace. For a detailed table of
contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth
through game
changer ideas and robust market & unmet
needs analysis. We are based in Dallas, TX and have
been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in
several publications like the Wall Street Journal, ZACKS, and the Financial
Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest
Publications
Power
Optimizer Market in Canada
Secondary
Water & Wastewater Treatment Equipment Market in Canada
Semiconductor
Cooling Module Market in Canada
No comments:
Post a Comment